gip/glp-1 agonist Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic GLP1-GIP receptor co-agonists: a promising
Description
These therapies are widely used in hospitals, specialty clinics, and outpatient settings, with growing applications in chronic weight management and cardiovascular risk reduction
GLP-1RAs have demonstrated optimal clinical efficacy when administered as a therapeutic intervention during the early stages of tumor development [36]
Diabet Med
The SLEEVEPASS trial demonstrated that patients who were randomly assigned to either a laparoscopy sleeve gastrectomy or a laparoscopic Roux-en-Y gastric bypass maintained a 43.5% and 50.7% excess weight loss a decade after the procedure
These symptoms are often worse when meals are large, greasy, spicy, or eaten too fast
[DOI] [PMC free article] [PubMed] [Google Scholar] 159.Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC
